144 related articles for article (PubMed ID: 38032452)
1. Detection of hepatocellular carcinoma during Fontan-associated liver disease follow-up: a report of three cases.
Onishi H; Toh N; Akagi T; Baba K; Kotani Y; Takaki A; Kasahara S; Ito H
Clin J Gastroenterol; 2024 Feb; 17(1):148-154. PubMed ID: 38032452
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment of hepatocellular carcinoma after Fontan operation: three case reports and review of the literature.
Shiraishi J; Itoh S; Tomino T; Yoshiya S; Nagao Y; Kayashima H; Harada N; Sakamoto I; Tsutsui H; Yoshizumi T
Clin J Gastroenterol; 2023 Aug; 16(4):559-566. PubMed ID: 37046144
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of hepatocellular carcinoma arising from Fontan-associated liver disease.
Sagawa T; Kogiso T; Sugiyama H; Hashimoto E; Yamamoto M; Tokushige K
Hepatol Res; 2020 Jul; 50(7):853-862. PubMed ID: 32219953
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for Fontan-associated hepatocellular carcinoma.
Kogiso T; Sagawa T; Taniai M; Shimada E; Inai K; Shinohara T; Tokushige K
PLoS One; 2022; 17(6):e0270230. PubMed ID: 35714161
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imaging: A prospective study.
Shao GL; Zheng JP; Guo LW; Chen YT; Zeng H; Yao Z
Medicine (Baltimore); 2017 Jan; 96(3):e5518. PubMed ID: 28099329
[TBL] [Abstract][Full Text] [Related]
6. Robust Effect of Hepatic Arterial Infusion Chemotherapy and Radiation Therapy on Hepatocellular Carcinoma Arising from Fontan-associated Liver Disease.
Suzuki H; Niizeki T; Shirono T; Koteda Y; Kinjyo Y; Mizukami N; Koda M; Ota S; Nakano M; Okamura S; Iwamoto H; Shimose S; Noda Y; Kamachi N; Kajiwara A; Suda K; Akiba J; Yano H; Kuromatsu R; Koga H; Torimura T
Intern Med; 2022 Apr; 61(8):1145-1150. PubMed ID: 34565776
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma and the Fontan circulation: Clinical presentation and outcomes.
Possner M; Gordon-Walker T; Egbe AC; Poterucha JT; Warnes CA; Connolly HM; Ginde S; Clift P; Kogon B; Book WM; Walker N; Wagenaar LJ; Moe T; Oechslin E; Kay WA; Norris M; Dillman JR; Trout AT; Anwar N; Hoskoppal A; Broering DC; Bzeizi K; Veldtman G
Int J Cardiol; 2021 Jan; 322():142-148. PubMed ID: 32828959
[TBL] [Abstract][Full Text] [Related]
8. Fontan-associated liver disease and hepatocellular carcinoma in adults.
Kogiso T; Tokushige K
Sci Rep; 2020 Dec; 10(1):21742. PubMed ID: 33303924
[TBL] [Abstract][Full Text] [Related]
9. A case of Fontan-related hepatocellular carcinoma successfully treated with proton beam therapy.
Ogasawara Y; Kogiso T; Sagawa T; Kodama K; Taniai M; Numajiri H; Sakurai H; Tokushige K
Clin J Gastroenterol; 2020 Feb; 13(1):73-78. PubMed ID: 31273674
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma diagnosed in a patient who had Fontan operation 30 years ago: a case report.
Hur MH; Kim H; Lee JH
J Liver Cancer; 2022 Sep; 22(2):188-193. PubMed ID: 37383407
[TBL] [Abstract][Full Text] [Related]
11. Liver Cirrhosis and/or Hepatocellular Carcinoma Occurring Late After the Fontan Procedure - A Nationwide Survey in Japan.
Kuwabara M; Niwa K; Toyoda T; Shirai T; Tateno S; Ohuchi H; Tanaka Y; Ichida F; Fujisawa T; Akagi T; Mori Y;
Circ J; 2018 Mar; 82(4):1155-1160. PubMed ID: 29445059
[TBL] [Abstract][Full Text] [Related]
12. Early detection of recurrent hepatocellular carcinoma.
Nishizaki T; Takenaka K; Yanaga K; Soejima Y; Uchiyama H; Kishikawa K; Sugimachi K
Hepatogastroenterology; 1997; 44(14):508-13. PubMed ID: 9164527
[TBL] [Abstract][Full Text] [Related]
13. Alpha fetoprotein changes predict hepatocellular carcinoma survival beyond the Milan criteria after hepatectomy.
Shen JY; Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
J Surg Res; 2017 Mar; 209():102-111. PubMed ID: 28032546
[TBL] [Abstract][Full Text] [Related]
14. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
15. Challenges in Accurate Diagnosis of HCC in FALD: A Case Series.
Feeley M; Hopkins K; Grinspan LT; Schiano T; Love B; Chan A; Lewis S; Zaidi AN
Pediatr Cardiol; 2023 Oct; 44(7):1447-1453. PubMed ID: 37318608
[TBL] [Abstract][Full Text] [Related]
16. Cone-Beam CT-Guided Chemoembolization in Patients with Complete Response after Previous Chemoembolization but Subsequent Elevated α-Fetoprotein without Overt Hepatocellular Carcinoma.
Wattanasatesiri T; Kim HC; Choi JW; Lee JH; Joo I; Hur S; Lee M; Jae HJ; Chung JW
J Vasc Interv Radiol; 2019 Aug; 30(8):1273-1280. PubMed ID: 31235410
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort.
Téllez L; Rodríguez de Santiago E; Minguez B; Payance A; Clemente A; Baiges A; Morales-Arraez D; La Mura V; Llop E; Garrido E; Garrido-Lestache E; Tasayco S; Bruno O; Prieto R; Montserrat S; Pons M; Olavarría A; Dos L; Legendre A; Jesús Del Cerro M; Bañares R; García-Pagán JC; Rautou PE; Albillos A;
J Hepatol; 2020 Apr; 72(4):702-710. PubMed ID: 31726116
[TBL] [Abstract][Full Text] [Related]
18. Fontan Liver Lesions: Not Always HCC.
Haeffele C; Aggarwal A; Lutchman G; Veldtman GR; Wu FM; Lui GK
JACC Case Rep; 2019 Aug; 1(2):175-178. PubMed ID: 34316779
[TBL] [Abstract][Full Text] [Related]
19. A patient with a large hepatocellular carcinoma alive 13 years after repeated transcatheter arterial chemoembolization and hepatectomy.
Asahara T; Dohi K; Nakahara H; Katayama K; Itamoto T; Sugino K; Ono E; Ito K; Azuma K; Shimamoto F
Hiroshima J Med Sci; 1999 Mar; 48(1):41-4. PubMed ID: 10213963
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma and focal nodular hyperplasia in patients with Fontan-associated liver disease: characterisation using dynamic gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MRI.
Shiina Y; Inai K; Sakai R; Tokushige K; Nagao M
Clin Radiol; 2023 Mar; 78(3):e197-e203. PubMed ID: 36481111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
